Pulse Biosciences, Inc. (6L8)
Market Closed
17 Jul, 20:00
XFRA 
€
23. 60
+0.8
+3.5088%
€
1.51B Market Cap
- P/E Ratio
- Div Yield
100 Volume
0 Eps
€ 22.8
Previous Close Want to track 6L8 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Pulse Biosciences, Inc. (6L8) Statistics
Valuation metrics
Market Cap 1.51B
Enterprise value 1.32B
Trailing P/E (ttm) -20.19
Forward P/E -14.2
PEG ratio -2.52
Price/Sales (ttm) 2,119.61
Price/Book (mrq) 27.5
Enterprise Value/Revenue 2,038.16
Enterprise Value/EBITDA -20.03
Overview
Shares outstanding 69.21M
Float 18.4M
Shares short -
% Held by insiders 0.73%
% Held by institutions 0.11%
Average volume (10 days) 286
Average volume (90 days) 182
Price summary
52-Week low 10.8
52-Week high 26
Beta 1.63
50-Day moving average 18.22
200-Day moving average 14.84
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.54%
Operating margin -47.76%
Operational effectiveness
Return on assets -0.45%
Return on equity -0.81%
Income Statement
Revenue (ttm) 646.24K
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -135.96K
EBITDA -65.74M
Net income to common (ttm) -64.17M
Diluted EPS (ttm) -0.94
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 58.79M
Total cash per share (mrq) 0.99
Total debt (mrq) 6.16M
Total Debt/Equity (mrq) 10.79
Current ratio (mrq) 7.26%
Book value per share (mrq) 0.84
Cash Flow
Cash flow statement -47.5M
Levered free cash flow (LFCF) -25.02M
